Novartis’s Cancer Treatment Pluvicto Shows Positive Results in Trial
In This Article:
Pluvicto demonstrated positive results in patients with PSMA-positive metastatic hormone-sensitive prostate cancer.
Oops, something went wrong
Pluvicto demonstrated positive results in patients with PSMA-positive metastatic hormone-sensitive prostate cancer.